Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG FULTON C GILLON K PEACOCK R STALHAMMAR NO

Citation: Kd. Bardhan et al., COST-EFFECTIVENESS (C-E) OF OMEPRAZOLE (OM) AND RANITIDINE (RAN) IN INTERMITTENT TREATMENT (IT) OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD), Gut, 41, 1997, pp. 203-203

Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG GILLON K PEACOCK R FULTON C

Citation: Kd. Bardhan et al., SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) - INTERMITTENT TREATMENT (IT) WITH OMEPRAZOLE (OM) AND RANITIDINE (RAN) AS A STRATEGY FOR MANAGEMENT, Gut, 41, 1997, pp. 203-203

Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG FULTON C GILLON K PEACOCK R WIKLUND I

Citation: Kd. Bardhan et al., THE IMPACT ON QUALITY-OF-LIFE IN INTERMITTENT TREATMENT (IT) WITH OMEPRAZOLE (OM) AND RANITIDINE (RAN) AS STRATEGIES FOR THE MANAGEMENT OF PATIENTS WITH SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD), Gastroenterology, 112(4), 1997, pp. 65-65

Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG FULTON C GILLON K PEACOCK R STALHAMMAR NO

Citation: Kd. Bardhan et al., COST-EFFECTIVENESS (C-E) OF OMEPRAZOLE (OM) AND RANITIDINE (RAN) IN INTERMITTENT TREATMENT (IT) OF SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD), Gastroenterology, 112(4), 1997, pp. 65-65

Authors: BARDHAN KD MULLERLISSNER S BIGARD MA PORRO GB PONCE J HOSIE J SCOTT M WEIR DG GILLON K PEACOCK R FULTON C

Citation: Kd. Bardhan et al., SYMPTOMATIC GASTROESOPHAGEAL REFLUX DISEASE (GERD) - INTERMITTENT TREATMENT (IT) WITH OMEPRAZOLE (OM) AND RANITIDINE (RAN) AS A STRATEGY FOR MANAGEMENT, Gastroenterology, 112(4), 1997, pp. 65-65

Authors: HUMPHRIES SE PEACOCK R DUNNING A LANE A GREEN F HAMSTEN A

Citation: Se. Humphries et al., IDENTIFICATION OF GENETIC-VARIATION THAT DETERMINES LEVELS OF PLASMA TRIGLYCERIDES AND HYPERCOAGULABILITY, Clinical genetics, 46(1), 1994, pp. 19-31